An Exploratory Phase I Study With Sorafenib in Addition to Vinflunine in Progressive Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelial Tract
Phase of Trial: Phase I
Latest Information Update: 16 Nov 2018
At a glance
- Drugs Sorafenib (Primary) ; Vinflunine (Primary)
- Indications Bladder cancer; Pelvic cancer; Renal cancer; Ureteral neoplasms; Urethral cancer; Urogenital cancer
- Focus Adverse reactions
- Acronyms VINSOR
- 16 Nov 2018 Results exploring the biomarker potential of tumor-derived extracellular vesicles (EVs) in plasma from a subset of the patients with different response profiles from VINSOR trial , presented at the 30th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.
- 07 Aug 2018 Status changed from active, no longer recruiting to completed.
- 28 Dec 2017 Planned End Date changed from 1 Mar 2017 to 1 Apr 2018.